|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 11/10/14 Unitedhealth Group Inc 10-Q 9/30/14 69:16M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 839K
2: EX-10.1 Material Contract HTML 29K
3: EX-10.2 Material Contract HTML 25K
4: EX-12.1 Statement re: Computation of Ratios HTML 32K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 37K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 25K
47: R1 Document and Entity Information Document HTML 40K
37: R2 Condensed Consolidated Balance Sheets HTML 128K
45: R3 Condensed Consolidated Balance Sheet HTML 41K
(Parenthetical)
49: R4 Condensed Consolidated Statements of Operations HTML 98K
64: R5 Condensed Consolidated Statements of Comprehensive HTML 61K
Income
39: R6 Condensed Consolidated Statements of Changes in HTML 66K
Shareholders' Equity
44: R7 Condensed Consolidated Statements of Cash Flows HTML 119K
33: R8 Basis of Presentation (Notes) HTML 35K
25: R9 Investments (Notes) HTML 286K
65: R10 Fair Value (Notes) HTML 326K
51: R11 Medicare Part D Pharmacy Benefits (Notes) HTML 40K
50: R12 Medical Cost Reserve Development (Notes) HTML 33K
55: R13 Commercial Paper and Long-Term Debt (Notes) HTML 168K
56: R14 Shareholders' Equity (Notes) HTML 41K
54: R15 Share-Based Compensation (Notes) HTML 105K
57: R16 Commitments and Contingencies (Notes) HTML 36K
46: R17 Segment Financial Information (Notes) HTML 321K
48: R18 Basis of Presentation (Policies) HTML 34K
53: R19 Investments (Tables) HTML 285K
69: R20 Fair Value (Tables) HTML 317K
60: R21 Medicare Part D Pharmacy Benefits (Tables) HTML 37K
41: R22 Medical Cost Reserve Development (Tables) HTML 34K
52: R23 Commercial Paper and Long-Term Debt (Tables) HTML 162K
43: R24 Shareholders' Equity (Tables) HTML 30K
19: R25 Share-Based Compensation (Tables) HTML 109K
61: R26 Segment Financial Information (Tables) HTML 315K
66: R27 Basis of Presentation (Details) HTML 23K
29: R28 Investments (Narrative) (Details) HTML 24K
28: R29 Investments (Short-Term and Long-Term Investments) HTML 80K
(Details)
31: R30 Investments (Fair Value of Mortgage-Backed HTML 51K
Securities by Credit Rating Origination) (Details)
32: R31 Investments (Amortized Cost and Fair Value of HTML 64K
Available-for-Sale Debt Securities by Contractual
Maturity) (Details)
34: R32 Investments (Amortized Cost and Fair Value of HTML 52K
Held-To-Maturity Debt Securities by Contractual
Maturity) (Details)
18: R33 Investments (Fair Value of Available-For-Sale HTML 57K
Investments with Gross Unrealized Losses by
Investment Type and Length of Time That Individual
Securities Have Been in a Continuous Unrealized
Loss Position) (Details)
58: R34 Investments (Net Realized Gains) (Details) HTML 46K
40: R35 Fair Value (Narrative) (Details) HTML 42K
42: R36 Fair Value (Financial Assets and Liabilities, HTML 74K
Excluding AARP, Measured at Fair Value on a
Recurring Basis) (Details)
22: R37 Fair Value (Financial Assets and Liabilities, HTML 61K
Excluding AARP, Not Measured at Fair Value on a
Recurring Basis) (Details)
68: R38 Fair Value (Reconciliation of Assets Measured at HTML 43K
Fair Value on a Recurring Basis Using Level 3
Inputs) (Details)
13: R39 Fair Value Fair Value Inputs Assets Quantitative HTML 32K
Information (Details)
35: R40 Fair Value (Assets and Liabilities measured at HTML 87K
fair value on a recurring basis) (Details)
63: R41 Medicare Part D Pharmacy Benefits (Details) HTML 26K
21: R42 Medical Cost Reserve Development (Details) HTML 26K
27: R43 Commercial Paper and Long-Term Debt (Narrative) HTML 61K
(Details)
30: R44 Commercial Paper and Long-Term Debt (Details) HTML 112K
38: R45 Shareholders' Equity (Details) HTML 33K
17: R46 Shareholders' Equity Dividends Paid (Details) HTML 27K
24: R47 Share-Based Compensation (Stock Option and SAR HTML 69K
Activity) (Details)
14: R48 Share-Based Compensation (Restricted Share HTML 38K
Activity) (Details)
62: R49 Share-Based Compensation Other Share-Based HTML 46K
Compensation Data (Details)
20: R50 Share-Based Compensation (Share-Based Compensation HTML 39K
Principal Fair Value Assumptions) (Details)
59: R51 Commitments and Contingencies (Details) HTML 34K
23: R52 Segment Financial Information (Narrative) HTML 22K
(Details)
36: R53 Segment Financial Information (Details) HTML 90K
67: XML IDEA XML File -- Filing Summary XML 100K
15: EXCEL IDEA Workbook of Financial Reports XLSX 285K
26: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 2.90M
7: EX-101.INS XBRL Instance -- unh-20140930 XML 4.74M
9: EX-101.CAL XBRL Calculations -- unh-20140930_cal XML 211K
10: EX-101.DEF XBRL Definitions -- unh-20140930_def XML 778K
11: EX-101.LAB XBRL Labels -- unh-20140930_lab XML 1.66M
12: EX-101.PRE XBRL Presentations -- unh-20140930_pre XML 964K
8: EX-101.SCH XBRL Schema -- unh-20140930 XSD 161K
16: ZIP XBRL Zipped Folder -- 0000731766-14-000051-xbrl Zip 278K
| UNH EX 32.1 9.30.2014 |
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
President and Chief Executive Officer | |
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company. |
Executive Vice President and Chief
Financial Officer of UnitedHealth Group and President of UnitedHealth Group Operations | |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/10/14 | None on these Dates | ||
| For Period end: | 9/30/14 | |||
| List all Filings | ||||